It was added that the company’s product is a generic version of the 25 mg Vemlidy pills produced by Gilead Sciences Inc. According to Lupin, the antiviral drug would be produced in its Nagpur facility.
On Friday, the pharmaceutical company Lupin announced that the US health agency had given the go-ahead for the marketing of a generic antiviral drug. Tenofovir Alafenamide tablets (25 mg) have been given the green light by the US Food and Drug Administration (USFDA), according to a statement from the Mumbai-based pharmaceutical company.
It was added that the company’s product is a generic version of the 25 mg Vemlidy pills produced by Gilead Sciences Inc. According to Lupin, the antiviral drug would be produced in its Nagpur facility.
Tenofovir Alafenamide tablets (25 mg) had annual sales in the US market of about USD 531 million, according to the IQVIA MAT December 2022 statistics.